Winner Medical Co Ltd (300888) - Net Assets

Latest as of March 2026: CN¥12.54 Billion CNY ≈ $1.84 Billion USD

Based on the latest financial reports, Winner Medical Co Ltd (300888) has net assets worth CN¥12.54 Billion CNY (≈ $1.84 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥18.48 Billion ≈ $2.70 Billion USD) and total liabilities (CN¥5.93 Billion ≈ $868.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Winner Medical Co Ltd assets under control for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥12.54 Billion
% of Total Assets	67.89%
Annual Growth Rate	26.35%
5-Year Change	15.02%
10-Year Change	643.51%
Growth Volatility	60.61

Winner Medical Co Ltd - Net Assets Trend (2013–2025)

This chart illustrates how Winner Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. Check how tangible is Winner Medical Co Ltd's equity to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Winner Medical Co Ltd (2013–2025)

The table below shows the annual net assets of Winner Medical Co Ltd from 2013 to 2025. For live valuation and market cap data, see market cap of Winner Medical Co Ltd.

Year	Net Assets	Change
2025-12-31	CN¥12.29 Billion ≈ $1.80 Billion	+3.51%
2024-12-31	CN¥11.88 Billion ≈ $1.74 Billion	-1.94%
2023-12-31	CN¥12.11 Billion ≈ $1.77 Billion	-0.72%
2022-12-31	CN¥12.20 Billion ≈ $1.78 Billion	+14.14%
2021-12-31	CN¥10.69 Billion ≈ $1.56 Billion	+2.68%
2020-12-31	CN¥10.41 Billion ≈ $1.52 Billion	+229.01%
2019-12-31	CN¥3.16 Billion ≈ $462.93 Million	+18.90%
2018-12-31	CN¥2.66 Billion ≈ $389.33 Million	+34.54%
2017-12-31	CN¥1.98 Billion ≈ $289.38 Million	+19.61%
2016-12-31	CN¥1.65 Billion ≈ $241.93 Million	+26.21%
2015-12-31	CN¥1.31 Billion ≈ $191.69 Million	+14.71%
2014-12-31	CN¥1.14 Billion ≈ $167.10 Million	+53.80%
2013-12-31	CN¥742.46 Million ≈ $108.65 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Winner Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 7058.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥7.14 Billion	62.00%
Other Components	CN¥4.38 Billion	38.00%
Total Equity	CN¥11.52 Billion	100.00%

Winner Medical Co Ltd Competitors by Market Cap

The table below lists competitors of Winner Medical Co Ltd ranked by their market capitalization.

Company	Market Cap
Timken India Limited NSE:TIMKEN	$2.62 Billion
Union Semiconductor (Hefei) Co. Ltd. A SHG:688403	$2.62 Billion
AXT Inc NASDAQ:AXTI	$2.62 Billion
SCG PACKAGING -NVDR- BA1 F:5Y7	$2.62 Billion
Russel Metals Inc. TO:RUS	$2.62 Billion
K+S Aktiengesellschaft F:SDF1	$2.61 Billion
Zhejiang Orient Holdings Co Ltd SHG:600120	$2.61 Billion
BSP Financial Group Ltd AU:BFL	$2.61 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Winner Medical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 11,151,279,644 to 11,516,711,030, a change of 365,431,386 (3.3%).
Net income of 767,967,462 contributed positively to equity growth.
Dividend payments of 606,825,040 reduced retained earnings.
Other comprehensive income decreased equity by 548,402,179.
Other factors increased equity by 752,691,144.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥767.97 Million	+6.67%
Dividends Paid	CN¥606.83 Million	-5.27%
Other Comprehensive Income	CN¥-548.40 Million	-4.76%
Other Changes	CN¥752.69 Million	+6.54%
Total Change	CN¥-	3.28%

Book Value vs Market Value Analysis

This analysis compares Winner Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.55x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 15.22x to 1.55x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-12-31	CN¥2.02	CN¥30.70	x
2014-12-31	CN¥3.10	CN¥30.70	x
2015-12-31	CN¥2.54	CN¥30.70	x
2016-12-31	CN¥3.20	CN¥30.70	x
2017-12-31	CN¥3.80	CN¥30.70	x
2018-12-31	CN¥5.09	CN¥30.70	x
2019-12-31	CN¥5.99	CN¥30.70	x
2020-12-31	CN¥19.07	CN¥30.70	x
2021-12-31	CN¥17.90	CN¥30.70	x
2022-12-31	CN¥19.81	CN¥30.70	x
2023-12-31	CN¥19.47	CN¥30.70	x
2024-12-31	CN¥19.08	CN¥30.70	x
2025-12-31	CN¥19.78	CN¥30.70	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Winner Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.67%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.01%
• Asset Turnover: 0.59x
• Equity Multiplier: 1.60x
Recent ROE (6.67%) is below the historical average (15.39%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	11.89%	6.93%	1.11x	1.54x	CN¥13.99 Million
2014	11.32%	8.55%	1.00x	1.32x	CN¥15.03 Million
2015	16.87%	12.12%	1.08x	1.29x	CN¥89.81 Million
2016	24.81%	16.00%	1.11x	1.39x	CN¥244.53 Million
2017	21.63%	12.21%	1.03x	1.72x	CN¥229.71 Million
2018	15.98%	11.06%	0.97x	1.49x	CN¥158.98 Million
2019	17.29%	11.94%	1.01x	1.43x	CN¥230.26 Million
2020	36.66%	30.40%	0.93x	1.30x	CN¥2.77 Billion
2021	11.61%	15.42%	0.61x	1.24x	CN¥171.83 Million
2022	14.09%	14.54%	0.62x	1.56x	CN¥478.76 Million
2023	5.03%	7.09%	0.48x	1.48x	CN¥-572.92 Million
2024	6.24%	7.75%	0.49x	1.65x	CN¥-419.75 Million
2025	6.67%	7.01%	0.59x	1.60x	CN¥-383.70 Million

Industry Comparison

This section compares Winner Medical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $3,322,746,428
Average return on equity (ROE) among peers: 11.18%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Winner Medical Co Ltd (300888)	CN¥12.54 Billion	11.89%	0.47x	$2.62 Billion
Beijing Centergate Technologies Holding Co Ltd (000931)	$1.79 Billion	0.80%	1.04x	$444.13 Million
Blue Sail Medical Co Ltd (002382)	$203.26 Million	29.44%	0.87x	$880.23 Million
Andon Health Co Ltd (002432)	$21.49 Billion	7.76%	0.23x	$4.40 Billion
Allmed Medical Products Co Ltd Class A (002950)	$2.06 Billion	15.82%	0.53x	$864.58 Million
Guangzhou Improve Med Instrument (300030)	$648.25 Million	5.50%	0.11x	$294.08 Million
QITIAN Technology Group Co Ltd (300061)	$408.78 Million	0.00%	0.59x	$634.52 Million
Shanghai Tofflon Science Tech (300171)	$3.09 Billion	3.99%	0.41x	$1.37 Billion
Truking Technology Ltd (300358)	$832.98 Million	18.84%	0.72x	$891.54 Million
Jiangxi Sanxin Medtec Co Ltd (300453)	$1.16 Billion	15.98%	0.55x	$750.22 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573)	$1.55 Billion	13.64%	0.15x	$1.54 Billion

About Winner Medical Co Ltd

SHE:300888 China Medical Instruments & Supplies

Market Cap

$2.62 Billion

CN¥17.88 Billion CNY

Market Cap Rank

#5262 Global

#906 in China

Share Price

CN¥30.70

Change (1 day)

+0.10%

52-Week Range

CN¥26.79 - CN¥43.30

All Time High

CN¥134.38